Watch MRVI. Know when insiders buy.
One email the day a filing lands. Free.
MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
6.97
−0.30 −4.13%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
14
FLAG · shorts 14
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $208.8M −5.0%NET INCOME −$77.4MNET DEBT $77M52W 2.69 – 9.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $51.4M | +8.5% | 40.1% | −$15.1M | −$12.4M | — | -0.08 | $4M | $370K | $3.6M | Aug 7 |
| Q1 2026 · Mar 31 | $65.8M | +40.5% | 51.2% | −$2.2M | −$3.7M | — | -0.02 | $8.7M | $4.4M | $4.2M | May 8 |
| Q4 2025 · Dec 31derived | $49.9M | −11.8% | 25.8% | −$58.8M | −$35.7M | — | -0.24 | −$22.8M | $2.1M | −$24.9M | Feb 26 |
| Q3 2025 · Sep 30 | $41.6M | −39.7% | 13.6% | −$41M | −$25.6M | — | -0.18 | −$15.2M | $3.7M | −$18.8M | Nov 7 |
| Q2 2025 · Jun 30 | $47.4M | −31.7% | 16.4% | −$66.3M | −$39.6M | — | -0.27 | −$10.3M | $2.9M | −$13.1M | Aug 7 |
| Q1 2025 · Mar 31 | $46.9M | −27.0% | 16.5% | −$49.2M | −$29.9M | — | -0.21 | −$9.4M | $4.5M | −$13.9M | May 8 |
| Q4 2024 · Dec 31derived | $56.6M | −23.7% | 34.3% | −$37.7M | −$25.9M | — | -0.18 | −$14.6M | $5.8M | −$20.5M | Feb 26 |
| Q3 2024 · Sep 30 | $69M | +3.2% | 46.7% | −$165.6M | −$97.1M | — | -0.68 | $13.1M | $8.6M | $4.5M | Nov 7 |
| Q2 2024 · Jun 30 | $69.4M | — | 44.4% | −$13.4M | −$9.8M | — | -0.07 | $17.4M | $9.6M | $7.9M | Aug 11 |
| Q1 2024 · Mar 31 | $64.2M | — | 40.3% | −$18.9M | −$12.1M | — | -0.09 | −$8.5M | $5.7M | −$14.1M | May 12 |
| Q4 2023 · Dec 31derived | $74.1M | — | 52.6% | −$7.2M | −$106M | — | -0.80 | $7.8M | $16.8M | −$9M | Feb 26 |
| Q3 2023 · Sep 30 | $66.9M | — | 45.1% | −$15.4M | −$6.5M | — | -0.05 | $14.2M | $15.8M | −$1.7M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $185.7M | 18.3% | −$215.3M | −$130.8M | -70.4% | -0.90 | −$57.6M | $13.1M | −$70.7M | — | — |
| FY2024 · to Dec 31 | $259.2M | 41.8% | −$235.6M | −$144.8M | -55.9% | -1.05 | $7.5M | $29.7M | −$22.2M | — | — |
| FY2023 · to Dec 31 | $288.9M | 48.5% | −$31.6M | −$119M | -41.2% | -0.90 | $126.2M | $65.6M | $60.7M | — | — |
| FY2022 · to Dec 31 | $883M | 80.9% | $574.2M | $220.2M | 24.9% | 1.67 | $536M | $17.1M | $518.9M | $0 | — |
| FY2021 · to Dec 31 | $799.2M | 82.4% | $554.6M | $182M | 22.8% | 1.56 | $368.6M | $14.8M | $353.7M | $0 | — |
| FY2020 · to Dec 31 | $284.1M | 72.0% | $119.9M | $89M | 31.3% | 2.36 | $152.2M | $25.4M | $126.8M | $33.7M | — |
Every number comes from MARAVAI LIFESCIENCES HOLDINGS, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.